4

OWNERSHIP DOCUMENT

Company: Hepion Pharmaceuticals, Inc.
Filed: May 20, 2021
Period of Report: May 18, 2021
Accession Number: 0001104659-21-069938

View Document ↗ View on SEC.gov ↗